The Hidden Challenges of Pharmaceutical Serialisation
This white paper looks at the challenges encountered during serialisation trials by the ‘early adopters’ and provides guidance on strategies to overcome them. Most trials were undertaken at a time before any legislative imperative or global standards and although these trials have not gone the full extent of serialisation and aggregation, the lessons learnt may prove invaluable.
Download the whitepaper to understand more about legislative requirements in the pharmaceutical sector and challenges facing pharmaceutical manufacturers as they begin serialisation and track and trace projects.
Get your copy now